143 related articles for article (PubMed ID: 6120812)
1. Intramuscular absorption and regional lymphatic uptake of liposome-entrapped inulin.
Jackson AJ
Drug Metab Dispos; 1981; 9(6):535-40. PubMed ID: 6120812
[TBL] [Abstract][Full Text] [Related]
2. Lymphatic delivery and pharmacokinetics of methotrexate after intramuscular injection of differently charged liposome-entrapped methotrexate to rats.
Kim CK; Han JH
J Microencapsul; 1995; 12(4):437-46. PubMed ID: 8583318
[TBL] [Abstract][Full Text] [Related]
3. The effect of route of administration on the disposition of inulin encapsulated in multilamellar vesicles of defined particle size.
Jackson AJ
Res Commun Chem Pathol Pharmacol; 1980 Feb; 27(2):293-304. PubMed ID: 7367749
[TBL] [Abstract][Full Text] [Related]
4. Lymphatic absorption and tissue disposition of liposome-entrapped [14C]adriamycin following intraperitoneal administration to rats.
Parker RJ; Hartman KD; Sieber SM
Cancer Res; 1981 Apr; 41(4):1311-7. PubMed ID: 7214320
[TBL] [Abstract][Full Text] [Related]
5. Influence of lipid composition on the antitumor activity exerted by doxorubicin-containing liposomes in a rat solid tumor model.
Storm G; Roerdink FH; Steerenberg PA; de Jong WH; Crommelin DJ
Cancer Res; 1987 Jul; 47(13):3366-72. PubMed ID: 3581073
[TBL] [Abstract][Full Text] [Related]
6. Comparison of lymphatic uptake, metabolism, excretion, and biodistribution of free and liposome-entrapped [14C]cytosine beta-D-arabinofuranoside following intraperitoneal administration to rats.
Parker RJ; Priester ER; Sieber SM
Drug Metab Dispos; 1982; 10(1):40-6. PubMed ID: 6124381
[TBL] [Abstract][Full Text] [Related]
7. Application of liposomes as potential cutaneous drug delivery systems. In vitro and in vivo investigation with radioactively labelled vesicles.
Fresta M; Puglisi G
J Drug Target; 1996; 4(2):95-101. PubMed ID: 8894969
[TBL] [Abstract][Full Text] [Related]
8. The use of a new radioactive-iodine labeled lipid marker to follow in vivo disposition of liposomes: comparison with an encapsulated aqueous space marker.
Abra RM; Schreier H; Szoka FC
Res Commun Chem Pathol Pharmacol; 1982 Aug; 37(2):199-213. PubMed ID: 7134628
[TBL] [Abstract][Full Text] [Related]
9. Retention of cytosine arabinoside in mouse lung following intravenous administration in liposomes of different size.
Hunt CA; Rustum YM; Mayhew E; Papahadjopoulos D
Drug Metab Dispos; 1979; 7(3):124-8. PubMed ID: 38080
[TBL] [Abstract][Full Text] [Related]
10. In vivo behavior and disposition of 3H-cholesteryl ether labeled liposomes following intravenous administration to mice: comparison with an incorporated 14C-inulin as an aqueous phase marker.
Anderson M; Paradis C; Omri AW
Cell Mol Biol Lett; 2002; 7(2):275. PubMed ID: 12097947
[No Abstract] [Full Text] [Related]
11. Liposome disposition in vivo: effects of pre-dosing with lipsomes.
Abra RM; Bosworth ME; Hunt CA
Res Commun Chem Pathol Pharmacol; 1980 Aug; 29(2):349-60. PubMed ID: 7414053
[TBL] [Abstract][Full Text] [Related]
12. Effect of liposome size and drug release properties on pharmacokinetics of encapsulated drug in rats.
Allen TM; Everest JM
J Pharmacol Exp Ther; 1983 Aug; 226(2):539-44. PubMed ID: 6875864
[TBL] [Abstract][Full Text] [Related]
13. The effect of entrapment in liposomes on the in vivo distribution of [3H]methotrexate in a primate.
Kimelberg HK; Tracy TF; Biddlecome SM; Bourke RS
Cancer Res; 1976 Aug; 36(8):2949-57. PubMed ID: 819137
[TBL] [Abstract][Full Text] [Related]
14. Intracellular digestion of saturated and unsaturated phospholipid liposomes by mucosal cells. Possible mechanism of transport of liposomally entrapped macromolecules across the isolated vascularly perfused rabbit ileum.
Patel HM; Tuzel NS; Stevenson RW
Biochim Biophys Acta; 1985 Mar; 839(1):40-9. PubMed ID: 3978120
[TBL] [Abstract][Full Text] [Related]
15. Preliminary observations on the absorption of liposome-encapsulated drug by the intestinal lymphatics.
Ueda CT; Nickols JG; Schmelter RF
Res Commun Chem Pathol Pharmacol; 1981 Jun; 32(3):487-98. PubMed ID: 7268193
[TBL] [Abstract][Full Text] [Related]
16. Biopharmaceutical evaluation of the liposomes prepared by rehydration of freeze-dried empty liposomes (FDELs) with an aqueous solution of a drug.
Yachi K; Harashima H; Kikuchi H; Sudo R; Yamauchi H; Ebihara K; Matsuo H; Funato K; Kiwada H
Biopharm Drug Dispos; 1996 Oct; 17(7):589-605. PubMed ID: 8894117
[TBL] [Abstract][Full Text] [Related]
17. Liposomes to target the lymphatics by subcutaneous administration.
Oussoren C; Storm G
Adv Drug Deliv Rev; 2001 Aug; 50(1-2):143-56. PubMed ID: 11489337
[TBL] [Abstract][Full Text] [Related]
18. Disposition of 3H-cholesteryl ether labeled liposomes following intravenous administration to mice: comparison with an encapsulated 14C-inulin as aqueous phase marker.
Anderson M; Paradis C; Omri A
Drug Deliv; 2003; 10(3):193-200. PubMed ID: 12944140
[TBL] [Abstract][Full Text] [Related]
19. Lymphatic transport of liposome-encapsulated agents: effects of liposome size following intraperitoneal administration.
Hirano K; Hunt CA
J Pharm Sci; 1985 Sep; 74(9):915-21. PubMed ID: 4067845
[TBL] [Abstract][Full Text] [Related]
20. Liposome disposition in vivo IV: the interaction of sequential doses of liposomes having different diameters.
Abra RM; Hunt CA
Res Commun Chem Pathol Pharmacol; 1982 Apr; 36(1):17-31. PubMed ID: 7079585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
